Table 7

Sensitivity to change of the ScleroID compared with other PROMs

VariableSRM (all)95% CI (all)SRM (improved)95% CI (improved)SRM (worsened)95% CI (worsened)
ScleroID0.57 (36)0.31 to 0.860.76 (20)0.42 to 1.23−2.31 (4)−25.14 to −1.35
Raynaud0.08 (37)−0.26 to 0.40.21 (20)−0.25 to 0.68−1.50 (4)− to −1.17
Hand function−0.20 (36)−0.57 to 0.11−0.22 (20)−0.77 to 0.22−0.78 (4)−3.5 to −0.5
Pain0.01 (37)−0.23 to 0.450.04 (20)−0.39 to 0.510.00 (4)−1.5 to 1.5
Fatigue0.24 (37)−0.08 to 0.540.40 (20)0 to 0.79−1.306 (4)− to −0.5
Upper GI symptoms0.56 (37)0.33 to 0.810.58 (20)0.25 to 0.99− (4)
Lower GI symptoms0.44 (37)0.09 to 0.820.43 (20)−0.03 to 1.07− (4)
Life Choices0.53 (37)0.25 to 0.870.77 (20)0.33 to 1.510.50 (4)0.5 to 1.5
Body mobility0.35 (37)0.03 to 0.630.54 (20)0.14 to 10.00 (4)−1.5 to 1.5
Dyspnoea0.50 (37)0.2 to 0.850.65 (20)0.25 to 1.240.00 (4)−1.5 to 1.5
Digital ulcers−0.09 (36)−0.43 to 0.230.00 (20)−0.62 to 0.39−0.5 (4)−1.5 to −0.5
Patient’s Global Assessment0.29 (36)−0.04 to 0.660.57 (20)0.22 to 1.02−0.20 (4)−1.5 to 1.5
Physician’s Global Assessment0.09 (29)−0.26 to 0.470.31 (17)−0.18 to 0.9−0.5 (4)−1.5 to −0.5
SF-36 Physical Component Score−0.2 (37)−0.53 to 0.08−0.45 (20)−0.85 to −0.0710.96 (4)9.25 to 128.35
SF-36 Mental Component Score−0.08 (37)−0.4 to 0.26−0.18 (20)−0.64 to 0.31−0.24 (4)−1.22 to 2.65
HAQ-DI−0.01 (36)−0.39 to 0.320.10 (19)−0.34 to 0.61−0.78 (4)−2.6 to −0.5
SSc HAQ0.15 (34)−0.23 to 0.450.24 (18)−0.26 to 0.69−0.46 (4)−5.5 to 0.5
EQ-5D0.41 (37)0.09 to 0.740.33 (20)−0.09 to 0.741.42 (4)1.25 to 9.94
  • EQ-5D, EuroQol Five Dimensional; GI, gastrointestinal; HAQ-DI, Health Assessment Questionnaire Disability Index; PROMs, patient-reported outcome measures; ScleroID, Systemic Sclerosis Impact of Disease; SF-36, Short Form (36) Health Survey; SRM, standardised response mean; SSc, systemic sclerosis.